Target Spinal Cord Perfusion Pressure After EVAR-Related Spinal Cord Ischemia
Maintain a spinal cord perfusion pressure (SCPP) ≥65 mmHg following spinal cord ischemia after endovascular aortic repair.
Primary Recommendation
The strongest evidence supports targeting SCPP ≥65 mmHg rather than focusing solely on mean arterial pressure (MAP) goals 1. This target is derived from prospective multicenter data demonstrating that SCPP between 60-65 mmHg was the best predictor of neurologic recovery, with clinical adherence to this range showing a positive linear relationship with improved outcomes 1.
Evidence Hierarchy and Rationale
SCPP Targets Over MAP Targets
SCPP >50 mmHg is the minimum threshold: Patients exposed to SCPP below 50 mmHg were significantly less likely to improve neurologically (p=0.0056), with relative risk for non-recovery continuously increasing below this level 2
Optimal range is 60-65 mmHg: Analysis of 92 acute SCI patients found SCPP (not MAP) was independently associated with positive neurologic recovery (OR 1.039, p=0.002), with adherence to 60-65 mmHg targets showing the strongest correlation with improvement 1
Historical surgical data supports ≥40 mmHg: Intraoperative monitoring during thoracoabdominal aortic surgery demonstrated that maintaining SCPP >40 mmHg prevented paraplegia, though this represents a lower threshold during controlled surgical conditions 3
Why SCPP Matters More Than MAP Alone
SCPP accounts for both arterial inflow (MAP) and intrathecal pressure (ITP), making it physiologically superior to MAP-only targets. The calculation is: SCPP = MAP - ITP. After aortic intervention, intrathecal pressure can be elevated due to cord edema and impaired CSF dynamics, meaning adequate MAP may still result in insufficient cord perfusion 4, 5.
Practical Implementation
Monitoring Approach
- Insert lumbar subarachnoid drain (LSAD) to measure ITP and calculate SCPP
- Continuous arterial line for real-time MAP monitoring
- Target SCPP ≥65 mmHg for the first 5-7 days post-injury
Management Algorithm
If SCPP <65 mmHg:
- First: Increase MAP with vasopressors (norepinephrine preferred)
- Second: Consider therapeutic CSF drainage if ITP elevated (typically >15-20 mmHg)
- Goal: Maintain SCPP ≥65 mmHg continuously
If SCPP remains <50 mmHg despite interventions:
- This represents critical hypoperfusion with high risk of permanent deficit
- Maximize both MAP augmentation and CSF drainage
- Consider urgent surgical decompression if cord compression present
Critical Caveats and Pitfalls
CSF Drainage Complexity
Recent multicenter trial data reveals that CSF drainage in traumatic/ischemic SCI is more complex than in elective TAAA surgery 6. The relationship between drainage volume and ITP reduction was unclear, likely due to subarachnoid space occlusion at the injury site from cord swelling. Only 27.8% of patients in one series required therapeutic CSF drainage 7, suggesting ITP elevation is not universal.
Key point: Do not assume CSF drainage will reliably lower ITP in the setting of acute cord ischemia. Monitor actual SCPP response rather than drainage volume.
Duration of Monitoring
- Minimum 5-7 days based on guideline recommendations for MAP management 8
- Recent protocols average 5.2 ± 1.8 days of SCPP monitoring 7
- SCPP recovery is gradual, continuing over the first 24 hours postoperatively 4
Safety Profile
Lumbar drain placement for SCPP monitoring has proven safe across multiple studies with no complications related to catheter placement or maintenance reported in recent series 7. This is substantially safer than the modest infectious risk associated with high-dose steroid protocols (which are NOT recommended) 8.
Comparison to Guideline MAP Targets
French guidelines recommend MAP ≥70 mmHg for traumatic SCI based on expert opinion 8. However, this represents a compromise position given insufficient evidence for higher targets (MAP 85-90 mmHg suggested by some North American guidelines). The guideline explicitly notes that SCPP >50 mmHg was correlated with better 6-month outcomes and that optimal MAP analysis suggested >70 mmHg 8.
The SCPP approach integrates and supersedes MAP-only targets by accounting for the actual perfusion pressure reaching the cord tissue.
Vasopressor Use
Approximately 44% of patients require vasopressor support when following SCPP protocols, typically for 3.1 ± 2.1 days 7. This is actually less frequent than MAP-only protocols 6, suggesting SCPP-directed therapy may reduce unnecessary vasopressor exposure while improving physiologic targeting.